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SURGICAL OUTCOMES OF PARS PLANA VITRECTOMY WITH AND 
WITHOUT INTERNAL LIMITING MMBRANE PEELING FOR 
SYMPTOMATIC VITREOMACULAR TRACTION 
ADAM P. STERN 
ABSTRACT 
Purpose: To study the long-term anatomic and visual outcomes after pars plana 
vitrectomy (PPV) with and without internal limiting membrane (ILM) peeling in patients 
with symptomatic vitreomacular traction (VMT). This study assesses the frequency of 
complications, changes in visual acuity, and changes in anatomical central macular 
thickness after macular surgery.   
Methods: This retrospective, single-site, single-surgeon study reviewed 40 medical 
records (45 eyes) of patients at the Beth Israel Deaconess Medical Center requiring PPV 
with ILM peeling (n=27) or without ILM peeling (n=18) for VMT between the years of 
2003 and 2016. Successful surgery was defined as the relief of anatomical traction, and 
the absence of a second surgery, or any post-operative complications (n=42). Visual 
acuity was documented for each eye prior to surgery and post surgery.   
Results: All 27 (100%) eyes that had ILM peeling had successfully resolved macular 
traction following a single surgery, and 15 of the 18 (83.3%) eyes without ILM peel were 
successful. None of 27 (0%) eyes that had ILM peeling required a second surgery, nor 
did they have complications. 3 of the 18 (16.7%) eyes without ILM peeling required a 
second surgery. Best corrected visual acuity (BCVA, logMAR) improved significantly in 
		 vii	
both groups: BCVA improved from 0.59 ± 0.29 preoperatively to 0.37 ± 0.25 
postoperatively  in eyes receiving ILM peeling and from 0.77 ± 0.37 to 0.53 ± 0.37 in 
eyes with PPV only. Mean change in CMT pre-operatively to post-operatively was found 
to be greater in eyes with PPV alone, but this difference was not statistically significant.  
Conclusions: Our case series shows that PPV with ILM peeling for VMT relieved 
macular traction better than PPV alone, although there was no significant difference in 
visual acuity outcomes or central macular thickness between the two groups. Further 
research is required to validate these findings.  
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INTRODUCTION 
 Basic Anatomy of the Human Eye 
 
 The human eye is a complex and intricate organ that is essential to providing the 
sense of sight. In order for humans to visualize the surrounding environment, light passes 
through different layers of the eye and is converted to neural impulses. The outermost 
layer of the eye includes the cornea, conjunctiva and the sclera. The cornea is a densely 
innervated tissue located on the anterior surface of the eye (25). Functions of the cornea 
include protecting the eye from structural damage and infection, and refracting light in 
combination with the lens of the eye, to focus light onto the retina (25). The sclera is a 
supportive, connective tissue layer that is responsible for maintaining the shape and 
intraocular pressure of the eye (13). It is also where extraocular muscles attach to the eye 
(13). The middle layer of the eye, also known as the uvea, is comprised of the choroid, 
Figure 1: Anatomy of the eye. Figure taken from Malhotra et al., 2011 (13). 
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the ciliary body, and the iris (13). The choroid is a vascular tissue underlying the 
posterior sclera, while the ciliary body adjusts the power and shape of the lens, and 
secretes aqueous humor, which fills the anterior chamber of the eye. The iris is 
responsible for changing the size of the pupil (13, 25). Lastly, the inner layer of the eye is 
the neural sensory retina (13). There are also three addditional transparent components 
within the ocular layers, the lens, the vitreous, and the aqueous (25).  
 The retina is a tissue consisting of ten layers of cells (inner limiting membrane 
(ILM), nerve fiber layer (NFL), ganglion cell layer (GCL), inner plexiform layer (IPL), 
inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), outer 
limiting membrane (OLM), rods and cones layer (R and CL), and retinal pigmented 
epithelium (RPE)). This tissue develops as two separate  
Figure 2: Layers of the retina. Figure taken from Willoughby et al., 2008 (25).  
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layers during embryogenesis; the neural retina is the inner sensory layer, and the retinal 
pigmented epithelium is the thin outer layer adjacent to the choroid (13). The neural 
retina consists of six different classes of neurons (photoreceptors, bipolar cells, horizontal 
cells, amacrine and ganglion cells, and the Müllerian glia) (25). These neurons help the 
retina perform its primary function, which is to capture and process visible light signals. 
The retinal pigment epithelium maintains photoreceptor function, stores and metabolizes 
vitamin A, and provides retinal adhesion (25). This pigmented epithelium is formed by a 
single layer of cells bound together by tight junctions, and which help to form the retinal 
blood barrier (13).  
  In the human eye the photoreceptor neurons are the rods and cones. These 
photoreceptors function by converting light into an electrical signal. The cones provide 
color vision, while the rods are only activated by low light conditions. Throughout the 
retina the density of the rods and cones differs depending on the region. In the center of 
Figure 3: Fundus photo of the eye. Taken from Willoughby et al., 2008 (25). 
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the retina is the macula, which contains approximately fifty percent of all cones (25). At 
the center of the macula is the fovea. The fovea has the highest concentration of cones 
and provides central vision (25). In clinical practice, the fovea is defined by the annular 
light reflex off the internal limiting membrane (ILM) (12).  
The ILM is the anterior basement membrane layer of the retina comprised of type 
IV collagen, glycoproteins, and Müller cells (12). The Müller cells of the ILM provide 
metabolic support, protection of the neurosensory retina, glutamate recycling, and 
exchange of waste products with the ganglion cells (14).  The ILM is attached to the 
vitreous, which is a gel composed of a meshwork of collagen fibrils, soluble proteins, 
salts, and hyaluronic acid, and occupies the area between the retina and the lens (13). The 
strength of adhesion of the vitreous to the retina depends on age, and the location in the 
eye (12). The ILM varies in thickness over the retina, and the adhesion is strongest where 
the ILM is thinnest, which is over the fovea (12). The ILM is 400 nm thick at the 
peripheral retina, but can be up to 1,400 nm thick in the macular area (14). Adhesion of 
the vitreous to the ILM is due to a biochemical glue-like substance consisting of 
proteoglycans, such as laminin and fibronectin (21).  
Background: Vitreomacular Traction Syndrome 
 The vitreous gel in the human eye gradually liquefies with age, and this natural 
process is usually accompanied by a weakening in adhesion of the posterior face of the 
vitreous to the ILM (20). Russel et al. (1995) used lectin probes to suggest that the 
weakening of adhesion is in part due to the lack of galactose β (1,3)-N-acetyl-
glucosamine, a component of the extracellular matrix, in adults (7, 17). By the age of 70 
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approximately half of the vitreous gel will have liquefied (20). As the vitreous liquefies 
and the adhesion to the ILM weakens, the vitreous can separate from the ILM. This is 
known as a posterior vitreous detachment (PVD). The average age of a complete PVD is 
around 60 years of age with an earlier onset found in patients with increasing severity of 
myopia (27). It has been shown that complete PVD often occurs gradually, and may 
begin focally in one quadrant of the perifoveal area with a superior predilection (20). 
Figure 4, taken from Johnson, Mark W. (2010), demonstrates stages of PVD. Attachment 
of the vitreous to the ILM usually persists to the optic nerve head and to the fovea (stage 
3 of Figure 4) before the completion of the PVD occurs (20). As the vitreous continues to 
liquefy, and adhesion strength continues to weaken, the liquid is able to penetrate the 
retrohyaloid space and any microbreaks that are present (10). This liquid entry assists in 
Figure 4: Drawing of the stages of PVD. Taken from Johnson, Mark 
W., 2010 (10). 
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the progression of the PVD (10). Eyes in which the vitreous liquefies quicker than normal, 
and before adequate weakening of adhesion may cause more complications due to PVD 
(19). PVD has been linked to a variety of pathologies such as epiretinal membranes, 
macular microholes, foveal red spot, and idiopathic macular holes (10).  
Incomplete PVD from the ILM can persist, leaving some vitreous still firmly 
attached to the macula (10, 20). Clinically, when macular adhesion is present with 
surrounding separation of the hyaloid from the retina without anatomical distortion of the 
macula, it is known as vitreomacular adhesion (VMA) (20). VMA thus may be 
asymptomatic in terms of visual acuity (20). If the adhesion begins to exert a traction 
force on the retina and distorts the retinal anatomy, it is defined clinically as 
vitreomacular traction (VMT) syndrome (20). Symptoms of VMT syndrome are 
distortion or blurriness in the central vision, and it may cause decreased visual acuity, 
tractional retinal detachments, epiretinal membranes, and macular edema (20, 22). VMT 
syndrome has also been suggested to be involved in the progression of diabetic 
retinopathy, and age-related macular degeneration (22). Therefore, if VMT syndrome is 
left untreated chronic traction may lead to further complications, long-term damage to 
photoreceptors, and potentially irreversible decreases in visual acuity (4). 
Diagnosis of VMT 
  Optical Coherence Tomography (OCT) has become an important tool in clinical 
practice for the diagnosis of various retinal pathologies. OCT is an imaging technique 
that uses the reflection of near-infrared light off tissues in order to create cross sectional 
images of morphological features on a micrometer scale (29). The OCT collects the  
	7 
Figure 5: High-resolution OCT of the retina with labels. Taken from Zysk et al. 2007, (29) 
 
 
reflected light and measures the differences in time of flight (5). The deeper the layer is, 
the longer the delay of the reflected light will be (5). OCT provides high-resolution 
images of different retinal features due to the contrasting structure, and therefore 
reflectivity of the layers of the retina (29). The layers that can be differentiated are the 
nerve fiber layer, the plexiform layers, the external limiting membrane, the retinal 
pigment epithelium, the photoreceptor layer, and the choriocapillaris (29).  
The relatively recent implementation of OCT in clinical practice has significantly 
assisted in diagnosing VMA versus VMT. Before the invention of OCT there was no 
adequate method for visualizing and assessing the different attachments and adhesions 
between the vitreous and the ILM (7). Diagnosing VMT without OCT is difficult due to 
the translucent adhesions often being imperceptible to the human eye, even with lens 
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Figure 6: OCT image of VMA. Taken from Simpson et al. (2012) (20). 
 
Figure 7: OCT image of VMT. Taken from Simpson et al., 2012, (20). 
 
examination (4). VMA and VMT can now be distinguished from one another through the 
high-resolution imaging provided by OCT. The quality of imaging provided by OCT has 
created some basic classifications of VMT and VMA (4). Based on the size of the 
diameter of the vitreoretinal adhesion, VMT can either be classified as focal (≤1500 µm) 
or broad (>1500 µm) (4, 7). Eyes in which the VMA is associated with another macular 
problem such as diabetic macular edema, retinal vein occlusion or age-related macular 
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degeneration are classified as concurrent VMA (7). The term isolated VMA is used when 
no ocular abnormalities are present (7). Figure 6 (taken from Simpson et al. 2012) depicts 
an excellent representation of isolated, focal VMA (20). In this image the posterior 
vitreous is attached to the fovea, but the surrounding hyaloid face is separated from the 
retina, and there is no distortion of the retinal anatomy (20). Figure 7 (taken from 
Simpson et al. 2012) demonstrates isolated, focal VMT syndrome because there are 
anatomical changes of the retina present due to tractional forces of the posterior vitreous 
surface on the ILM (20). A common anatomical change seen in the retina due to VMT 
syndrome is macular edema. Macular edema can be seen on OCT images, and this 
swelling due to the traction in the retina can be quantified by OCT. Central macular 
thickness is often used to quantify the severity of traction, edema, or other abnormalities 
in the retina. One limit to OCT is that the actual force from the traction on the fovea 
cannot yet be measured, however, it is expected that as the area of adhesion decreases the 
traction force on the fovea will increase (4).  
Treatment of VMT 
 Patients with VMT syndrome often present with good visual acuity and minimal 
structural changes to the retina and thus do not require immediate treatment (4). In some 
instances, VMT syndrome can resolve spontaneously by natural PVD and can often have 
favorable anatomic and functional outcomes (4, 23). This spontaneous resolution of VMT 
has been reported to occur in 11% of eyes over a five-year period (9). Many cases, 
however, do manifest progressive macular traction and decreasing visual acuity and 
require surgical intervention (4).  
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The current standard for treatment of severe VMT syndrome is a surgical 
intervention with pars plana vitrectomy (PPV) (9). The PPV procedure was first 
developed by Robert Machemer in 1972 using a 14-gauge (2.1-mm diameter) instrument 
(9). A successful PPV separates the posterior surface of the vitreous from the ILM, thus 
creating a PVD. Today, small gauge vitrectomy using a 23-gauge, 25-gauge, or 27-gauge 
instrument is the preferred method. A survey conducted in 2007 indicated that eighty 
percent of retina surgeons used small gauge vitrectomy in most of their cases (15). Small 
gauge vitrectomy allows for the use of smaller instrumentation. This smaller 
instrumentation means that the incision made into the sclera, known as sclerotomies, do 
not require suturing post surgery. Smaller incisions and lack of sutures in modern PPV 
has led to reduced inflammation, patient discomfort, and recovery time (15). Smaller 
gauge vitrectomy also decreases the overall duration of the surgery (24).  
Known as a three-port procedure, 23 and 27-gauge PPV require three 
sclerotomies. One port is for the infusion cannula, one is for instrumentation, and the 
third is for endoillumination, all of which are passed into the vitreous cavity via the pars 
plana (15, 24). Cannulas are used to facilitate the passing of instruments (15). These 
cannulas keep the conjunctival and scleral openings patent, and they are removed upon 
completion of the surgery (15).  They are inserted at an oblique angle (longer path) 
because the sclerotomies seal better and leak less when the instruments are removed (24). 
A vitreous infusion suction cutter, which can make several thousand cuts per minute, is 
used to separate the posterior surface of the vitreous from the ILM during a PPV (15, 24). 
In a simple case of traction with no other macular abnormalities, a simple PPV will 
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relieve the traction. A large-scale retrospective review of PPV for VMT syndrome by 
Jackson et al (2013) provided evidence for both the safety and the efficacy of using this 
procedure to treat VMT, as visual acuity improvement was observed in most eyes 
postoperatively, and the rate and types of complications were within expected values (9). 
  As with any surgery, there exists a potential for complications when performing 
a PPV. Complications of PPV include infection, retinal tears and detachments, cataract 
formation, and increased risk of developing glaucoma (28). Previously, the only 
treatment options for VMT were PPV or observation (28). However, new treatment 
options have become available for relieving VMT syndrome without requiring surgery. 
Enzymatic and non-enzymatic pneumatic vitreolysis are now being used in clinical 
practice often as a first attempt to resolve VMT syndrome. Enzymatic pneumatic 
vitreolysis works via an enzyme introduced to the vitreomacular interface by an 
intravitreal injection (22). One example is intravitreal Ocriplasmin. This treatment is an 
enzymatic form of a human serine protease plasmin with activity against fibronectin and 
laminin, and is another recently approved treatment option for VMT (22). Intravitreal 
Ocriplasmin has also resulted in a variety of complications such as retinal tears and 
detachments, retinal breaks, reduced visual acuity, and vitreous floaters (28). Non-
enzymatic pneumatic vitreolysis is the introduction of a small gas bubble to the 
vitreomacular interface through an intravitreal injection. The introduction of the gas 
bubble forces separation of the remaining adhesion to the macula. Though pneumatic 
vitreolysis has been shown to relieve VMT in a less invasive way than PPV, it does not 
resolve VMT in all cases, and patients may still require PPV (22).   
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Peeling the Internal Limiting Membrane 
While performing PPV for VMT, it may sometimes be necessary to peel the ILM. 
This step is especially necessary in cases where the traction has caused a macular hole, as 
the ILM can cause traction at the edges of the hole if it is not removed during surgery 
(14). Also, peeling the ILM during surgery for macular holes appears to stimulate the 
Müller cells, which stimulate wound healing through depolarization of underlying cells 
(14).  In order to peel the ILM, complete removal of the posterior hyaloid is necessary (1). 
Since the ILM can act as a scaffold for cellular proliferation, removal of the ILM 
prevents subsequent traction on the retina from adhesion to the posterior hyaloid by 
newly proliferated cells (1, 14). An ultrastructural evaluation of epiretinal membrane 
tissue peeled during vitrectomy surgery for VMT discovered fibrocellular membranes 
made up of fragments of the ILM, fibrous astrocytes, fibrocytes, collagen, and 
myofibroblasts (8). However, studies have not yet clarified the pathology of the ILM in 
persistent VMT caused by fibrocellular proliferation (8).  
In order to safely and effectively remove the ILM, many surgeons use dyes to 
stain, and thus visualize the ILM during surgery. A dye often used by surgeons for 
removal of the ILM is Indocyanine Green (ICG). ICG stains the extracellular matrix 
components of the ILM, such as type IV collagen, laminin, and fibronectin (16). Using 
ICG during PPV surgery selectively stains the ILM and assists in its complete removal, 
thus reducing the time of the operation and the potential for trauma to the retina (1). 
There are conflicting studies over the outcomes for visual acuity, recurrent epiretinal 
membrane, and macular edema when using ICG in idiopathic macular hole surgery, but 
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more recent studies indicate better outcomes with use of ICG (16). ICG does have the 
potential for toxicity on the retina and may persist after surgery for up to 36 months (16). 
However, other complications may include retinal pigmented epithelium changes, visual 
field defects, and optic nerve atrophy (16).  
 
 
 
 
 
 
 
 
 
 
 
        
           
           Figure 9: ICG dye stained ILM during surgery. Taken from Rodrigues et al. 2009, (16) 
 
 
To peel the ILM there are several instruments and techniques available for a 
surgeon to use during PPV. Creating an initial flap is the first step in any ILM peel, 
which can be accomplished by using pick forceps, a bent MVR blade, or vitreoretinal 
forceps (1). There are a variety of methods for peeling the ILM once the ILM flap is 
created, including using ILM forceps, a blunt retinal pick, fluidic ILM separation, and 
passive aspiration through a tapered needle (1). There are conflicting clinical studies 
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about the visual acuity results and the effect on the functionality of the retina when the 
ILM is peeled during surgery (14). One case series showed that the BCVA of 79.2% of 
eyes improved by 3 Snellen lines after macular hole surgery with ILM peeling, while 
BCVA improvement was found in just 44.8% of eyes that did not have the ILM peeled (2, 
14). However, a different case series had results of comparable visual acuity after six 
months regardless of whether the ILM was peeled or not (14). Complications of peeling 
the ILM are similar to those when the ILM is not peeled (1). These complications are 
retinal tears and detachments, progression of cataracts, vitreous hemorrhage, and 
endophthalmitis (1). 
PPV surgeries for treatment of macular holes, diabetic macular edema, 
complicated retinal detachments, and epiretinal membranes have been linked to epiretinal 
membrane (ERM) formation (3). Peeling of the ILM during PPV for macular holes has 
been shown to have a higher anatomical success rate compared to ERM dissection alone 
or no dissection (2). ERM development can cause decreased visual acuity, limit 
functionality of the retina, and require further surgery (3). ERM can develop due to VMT 
and progressing PVD when dehiscences in the ILM occur, allowing migration and 
proliferation of glial cells on the inner retinal surface (8). One study showed that peeling 
of the ILM during PPV for complicated retinal detachments prevented ERM formation 
and saw no negative effects in visual acuity outcomes (8). However, there is evidence 
that peeling of the ILM during PPV for macular holes results in initially better visual 
acuities, but the final visual results remain similar (2). Peeling of the ILM currently 
remains as a decision to be made by the surgeon on a case-by-case basis depending on 
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each individual diagnosis. Studies for ILM peeling during the treatment of macular holes 
are mentioned throughout this research as a comparison because there are few 
investigations currently on the treatment of VMT with ILM peeling.  
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SPECIFIC AIMS 
 
The objective of this single-site, single-surgeon investigation is to retrospectively 
assess the outcomes of pars plana vitrectomy surgery with and without internal limiting 
membrane peeling to resolve vitreomacular traction. The goal is to determine whether 
there is a statistically significant difference in surgical success between PPV with ILM 
peeling and PPV alone based on clinical examination of relief from traction, changes in 
central macular thickness, follow-up surgery due to complications, and visual acuity 
outcomes. The purpose of this research is to provide useful information for surgical 
treatment of vitreomacular traction in clinical practice by using over ten years (2003-
2016) of data from a single vitreoretinal surgeon. Furthermore, this study may provide 
supplementary insight into the on-going discussion in medical literature of the clinical 
outcomes resulting from peeling the internal limiting membrane. This controlled, 
retrospective investigation and statistical analysis in context with related vitreoretinal 
surgery publications also aims to help guide future surgical technique decisions and 
research inquiries.   
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METHODS 
  After receiving International Review Board approval for this retrospective 
clinical case series 40 medical records were reviewed for a single surgeon’s patients at 
the Beth Israel Deaconess Medical Center located in Boston, Massachusetts. A total of 45 
eyes from these 40 patients were included in this study. These patient’s charts were 
identified and included in this study based on pre-operative diagnosis. All patients that 
received PPV for VMT were included in this study. These 45 eyes underwent surgery 
between 2003 and 2016 for treatment of vitreomacular traction using two distinct surgical 
techniques. All surgical procedures were three-port 23 or 27-gauge pars plana vitrectomy 
with or without internal limiting membrane peeling. Some surgeries involved epiretinal 
membrane peeling. Prior to vitrectomy, eyes with a visually significant cataract 
underwent phacoemulsification and posterior chamber intraocular lens placement. 
Patients were examined in follow-up post-operative day 1 to determine if vitreomacular 
traction was anatomically relieved or persistent. Patients were then examined 3 months, 
and 12 months after surgery. For this clinical case series, the 12-month time point may 
range from 9 months to 10 years depending on available patient data in follow up. If 
patients had multiple follow up visits, the visit closest to 12 months after surgery was 
used. The Secondary operations were performed in some cases if complications arose 
postoperatively.  
Pre-Operative Consult 
Prior to any surgical procedures, patients were seen for a pre-operative consult to 
determine the diagnosis and discuss treatment options. All patients were examined, 
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diagnosed, and given background information on vitreomacular traction by a board-
certified, medically licensed ophthalmologist. Informed diagnosis was made through use 
of ophthalmoscopic examination and confirmed with OCT imaging. Information 
discussed with patients included but was not limited to mechanism for development of 
vitreomacular traction, typical age of onset, low occurrence rate of spontaneous 
anatomical relief from traction, and visual prognosis. Next the physician discussed the 
treatment options of observation versus pars plana vitrectomy surgery with the patient, 
weighing the benefits and risks of both treatment options. Patients were also informed of 
the high rate of success in relieving traction with a single surgery.  
 When surgical intervention was selected as the proper course of action, patients 
were informed that there is a one in one thousand risk of infection and bleeding with any 
ocular surgery, and these may lead to further complications, which can result in complete 
loss of vision. Patients were also informed of the one in one hundred risk for the 
development of retinal tears or detachments during surgery and that these complications 
can be fixed at the time of surgery and only in rare cases require a second surgery. Since 
many patients already had or were at risk for developing visually significant cataracts, the 
physician often recommended performing cataract removal and intraocular lens 
placement combined with PPV. Once the physician had presented the indications, risks, 
and benefits, patients signed consent forms and were scheduled for surgery. Patients were 
given instructions to fast after midnight prior to the day of surgery and to take any 
medications with a sip of water the morning of surgery.  
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Surgical Procedure 
 On the day of surgery, each patient was brought to the operating room, and 
monitors for oxygen and blood pressure, as well as an electrocardiogram were placed on 
the patient to monitor vitals during surgery. The operative eye was pharmacologically 
dilated, draped and then prepped, as is standard in ophthalmic surgery. A wire lid 
speculum was placed to keep the eyelids apart through the duration of the operation. The 
eye was anesthetized and akinesia was produced by a retrobulbar infusion behind the eye 
of a 50:50 mixture of 2% lidocaine and 0.75% Marcaine with epinephrine. Three 
sclerotomies were made 3.5 mm posterior to the limbus in the superonasal, 
superotemporal, and inferotemporal quadrants. The 4 mm inusion cannula was then 
inserted into the inferotemporal sclerotomy, and was inspected to ensure it was properly 
placed in the vitreous cavity before infusion took place.  
 Phacoemulsification and posterior chamber intraocular lens placement for cases 
requiring cataract extraction were performed and completed prior to vitrectomy (n=23). 
Kenalog dye was injected into the vitreous to stain the vitreous and the retina. 
Vitreomacular traction was identified, and was peeled using a soft tip aspirating cannula, 
followed by the vitreous cutter. Complete peripheral and central vitrectomy was then 
performed using the vitreous cutter and light pipe. If during vitrectomy the posterior 
hyaloid was noted to still be attached to the retina, the vitreous cutter was set to aspiration 
in order to peel the posterior hyaloid off the surface of the retina and macula to ensure a 
good peripheral vitrectomy could be performed.          
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 If an epiretinal membrane was present, it was stained using kenalog and peeled 
off of the macula using ILM forceps. For cases in which the ILM was peeled, ICG was 
used to stain the ILM for 45 seconds to one minute. Next, the ILM was grasped using the 
ILM forceps, and an edge was created in the ILM. The ILM was then completely peeled 
off the macula and the fovea in a 360-degree circular fashion. After the ILM was peeled, 
a 360-degree scleral depressed examination was performed to check for evidence of 
retinal tears or detachments. If any tears or detachments were noted, they were fixed at 
this time. The sclerotomies were then closed and checked to ensure they were watertight. 
The intraocular pressure was checked, and a subconjunctival injection of Kefzol and 
dexamethasone was given. The operative eye was patched with a drop of scopolamine 
0.25%, Bacitracin ointment, a soft eye pad, and a hard eye shield. The patient was then 
brought back to the recovery room. Patients followed up on postoperative day one to 
have the patch removed, and were given instructions for proper application of topical eye 
drops and ointment.  
Successful Outcome Measures 
 In order to determine successful outcomes in this study, the three measures of 
anatomical relief of traction on the retina, requirement of further surgery, and 
postoperative best-corrected visual acuity were taken into consideration. Relief of 
traction on the retina was initially examined before the conclusion of surgery, and further 
assessed upon patient follow up with OCT image assistance. If the anatomical traction on 
the retina was relieved, and the eye did not require a second surgery due to complications 
arising from the first surgery, the surgery was deemed anatomically successful. When 
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possible, best corrected visual acuities (BCVA) pre- and postoperatively were recorded 
and assessed based on medical records and notes made during visits to the eye clinic. 
Central macular thickness (CMT) was recorded pre- and postoperatively in order to 
provide an alternative to BCVA for comparing long-term success of cases that underwent 
ILM peeling and cases that did not. Surgical pre-and postoperative notes were used to 
record specific diagnosis and conditions of each procedure. Statistical methods used in 
this study were paired and unpaired t test, as well as chi squared test at P<0.05.  
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RESULTS 
After the medical records were reviewed, the surgical VMT cases were placed 
into two separate groups: those who underwent PPV with ILM peeling (Group 1, 27 
eyes) and those who underwent PPV alone (Group 2, 18 eyes). Table 1 displays a 
summary of the patient demographics for this study.  
Table 1: Patient Demographics  
 Total (n=45) Group 1 (n=27) Group 2 (n=18) 
Sex (Male/Female) 14 / 28 9 / 18 8 / 10 
Mean age ± SD (years) 71.6 ± 10.8 71.3 ± 11.6 72.1 ± 9.8 
Age range (years) 40 - 92 40 - 92 55 - 89 
 
 This series consisted of 14 male and 28 female patients with an average age of 
71.6 years at the time of the operation. Age at the time of operation ranged from 40 to 92 
years.  Preoperative and operative notes dictated by the surgeon were used to record 
indications for surgical intervention, and OCT images were reviewed to confirm these 
diagnosis. Cases were required to have a preoperative and operative diagnosis of VMT in 
order to be included in this study. The most common indications other than VMT were 
visually significant cataracts, epiretinal membranes, and macular holes. Table 2 provides 
information of the indications in this investigation. 
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Table 2: Indications for Surgical Intervention     
 Total (n=45) Group 1 (n=27) Group 2 (n=18) 
Vitreomacular traction 45 27 18 
Visually-significant cataract 23 13 10 
Epiretinal Membrane 15 9 6 
Macular Hole 5 4 1 
 
 Anatomical relief of traction on the retina occurred in all 45 cases (100%), 
regardless of whether or not the ILM was peeled. Eyes were examined at the end of 
surgery, on postoperative day 1, and during further follow up for relief of traction. OCT 
imaging was used to further confirm relief of traction on the retina. All 27 eyes that 
underwent PPV with ILM peeling (100%) and 15 of 18 eyes that did not undergo ILM 
peeling (83.3%) had complete VMT resolution after a single surgery and did not require 
follow-up surgery due to complications. Three of the 18 eyes that did not have the ILM 
peeled required a follow-up PPV surgery due to the formation of an epiretinal membrane. 
These surgical success results are summarized in table 3. 	
Table 3: Surgical Success Rates 
 Group 1 (n=27) Group 2 (n=18) 
Eyes not requiring a 
second surgery 
27/27 (100%) 15/18 (83.3%) 
Eyes requiring a second 
surgery 
0/27 (0%) 3/18 (16.7%) 
P Value: Difference 
Between Groups 
0.028 
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Best-corrected visual acuity (BCVA) was recorded for patients preoperatively and 
postoperatively at 3 months, 6 months, and 12 months when available. Of the 27 eyes in 
group 1, 17 had data for 12 months post operation, and of the 18 eyes in group 2, 10 had 
data available for 12 months post operation. In this case series 12 months may be 
anywhere from 9 months to 10 years, as needed, since long-term outcomes are the focus. 
The 3-month postoperative time point was included as it is an ongoing discussion in the 
current scientific literature regarding ILM peeling. Group 1 and group 2 had data for 16 
and 11 eyes respectively at the 3-month post operation follow up. For the purposes of this 
study 3 month data ranges from 1 month to 5 months. There was not enough available 
data at the 6 month time point to perform statistical analysis. Visual acuity data was 
converted to LogMAR units and is listed in Tables 4 and 5 below. LogMAR units are 
used to convert Snellen line readings (for example 20/25) into statistically quantifiable 
numbers (0.1). The lower the LogMAR units, the better the visual acuity is.    
Table 4: Mean BCVA preoperatively and 12 months postoperatively   
 
 
Table 5: Mean BCVA preoperatively and 3 months postoperatively  
 Group 1 (n=17) Group 2 (n=10) P Value 
Preoperative BCVA ± SD 0.59 ± 0.29 0.77 ± 0.37 0.106 
12 month BCVA ± SD 0.37 ± 0.25 0.53 ± 0.37 0.279 
12 month BCVA change ± SD 0.22 ± 0.31 0.24 ± 0.25 0.56 
 Group 1 (n=16) Group 2 (n=11) P Value 
Preoperative BCVA ± SD 0.60 ± 0.33 0.92 ± 0.41 0.019 
3 month BCVA ± SD 0.56 ± 0.38 0.72 ± 0.58 0.272 
3 month BCVA change ± SD 0.04 ± 0.04 0.20 ± 0.17 0.195 
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For patients in Group 1 with available BCVA data at 12 months postoperatively, 
the weighted mean preoperative BCVA was 0.59 ± 0.29. Vision improved over 12 
months by a weighted mean of 0.22 ± 0.31 to 0.37 ± 0.25 (approximately 2 Snellen lines). 
This difference between pre and postoperative vision was statistically significant (P = 
0.0054). Patients in Group 2 with available BCVA data had a weighted mean 
preoperative BCVA of 0.77 ± 0.37, which was improved by a weighted mean of 0.24 ± 
0.25 to 0.53 ± 0.37 (approximately 2 Snellen lines) at 12 months postoperatively. Thus, 
the difference between pre and postoperative BCVA in Group 2 was also found to be a 
statistically significant (P = 0.0065). However, there was no statistically significant 
difference between BCVA improvement of Group 1 and Group 2 at 12 months 
postoperatively (P = 0.56).  
        Figure 9: Group 1 LogMAR weighted BCVA over time 
Group 1 BCVA 
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The average BCVA improvement from the preoperative to 3 month postoperative 
time points was 0.04 ± 0.04 to 0.56 ± 0.38 for Group 1 and 0.20 ± 0.17 to 0.72 ± 0.58 for 
Group 2. Neither of these improvements was statistically significant (P >0.05). There was 
also no statistically significant difference in the BCVA improvement for this time period 
between the two groups (P = 0.195).  
Data for central macular thickness (CMT) was gathered from 15 patients in Group 
1 and 8 patients in Group 2. The average decrease in CMT was 119.6 ± 58.7 µm for 
Group 1 (416.4 ± 130.7 µm preoperatively to 296.8 ± 72.0 µm postoperatively) and  
246.8 ± 182.4 µm for Group 2 (511.4 ± 254.0 µm preoperatively to 306.1 ± 71.6 µm 
postoperatively). Both groups had statistically significant decreases in CMT (P1 = 0.0040 
and P2 = 0.045). While the average decrease in CMT was found to be greater for Group 2, 
Figure 10: Group 2 logMAR weighted BCVA over time 
Group 2 BCVA 
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this difference was not statistically significant (P = 0.118).  
Table 6: Mean CMT pre- and postoperatively  
 Group 1 (n=15) Group 2 (n= 8) P value 
Preoperative mean CMT (µm) 416.4 ± 130.7 511.4 ± 254.0 0.131 
Postoperative mean CMT (µm) 296.8 ± 72.0 306.1 ± 71.6 0.309 
Change in CMT (µm) 119.6 ± 58.7 246.8 ± 182.4 0.118 
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DISCUSSION 
 
Our retrospective case series demonstrates a similar surgical success rate, defined 
as complete VMT release after a single surgery with no follow-up surgery for 
complications, to that reported in the current scientific literature. As expected, initial 
traction relief was achieved after PPV in 100% of cases regardless of ILM peeling. 
Performing a PPV involves creating a posterior vitreous detachment, which relieves the 
traction on the retina. For cases in which the vitreous is difficult to separate from the ILM, 
posterior hyaloid peeling can be used to ensure relief of traction. Peeling of the ILM 
during PPV in Group 1 was 100% successful (27/27) in resolving VMT without requiring 
a second surgery due to the formation of an epiretinal membrane (ERM). PPV alone for 
Group 2 saw an 83.3% surgical success rate (15/18) in terms of requiring a second 
surgery with a 16.7% rate of postoperative formation of visually significant ERM 
requiring surgical intervention (3/18). Kiss et al. (2007) and Cox et al. (1995) report 
similar rates of postoperative ERM formation (20% of cases) when the ILM is not peeled 
during PPV (3, 6, 11). All 3 cases (100%) in this current study that required follow-up 
surgery for ERM underwent phacoemulsification and posterior chamber intraocular lens 
placement at the time of the original PPV for VMT, and ERM was diagnosed 
preoperatively in 2 of these 3 cases (66.7%). Therefore, 3 of the 6 eyes in Group 2 (50%) 
diagnosed with ERM prior to surgery had a recurrence, while none of the 9 eyes in Group 
1 diagnosed with ERM preoperatively required follow-up surgical intervention. The 
difference in rate of follow-up surgery for postoperative ERM between the two groups 
was found to be statistically significant (P=0.028)  
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Previous studies have indicated a general trend in increased ERM recurrence in 
eyes that underwent combined ERM peeling and phacoemulsification without ILM 
peeling and have also shown decreased incidence of ERM recurrence in cases that 
received ILM peeling (26). Other studies indicate that ERM recurrence following 
combined ERM and ILM removal occurs in approximately 9% of ERM removal cases, 
whereas surgical removal of the ERM alone results in recurrent ERM in 7.5% to 56% of 
cases (1). The mechanism and pathogenesis of formation of ERM post PPV surgery has 
not been fully elucidated at this time. However, multiple studies in the current scientific 
literature present significant evidence that ILM peeling may prevent postoperative ERM 
formation.  
 Both groups of patients in our study had statistically significant increases in best-
corrected visual acuity after 12 months, but there was no statistically significant 
difference in the changes in BCVA between the two surgical techniques. A meta analysis 
by Jackson et al. (2013) examined similar cases of PPV with and without ILM peel for 
VMT and found an average visual acuity improvement of 0.28 LogMAR units, from 0.72 
± 0.46 prior to surgery to 0.44 ± 0.37 after surgery, following PPV alone (9). They also 
reported an improvement from 0.64 ± 0.32 preoperatively to 0.41 ± 0.26 post-PPV for 
cases receiving PPV and ILM peeling, which was a change of 0.23 logMAR units (9). 
These results are consistent with the results from our current study, and are displayed in 
Table 7. Long-term visual acuity results for other retinal abnormalities treated with PPV 
and ILM peeling, such as diabetic macular edema, macular holes, and complicated retinal 
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detachments, in most cases appear to show no statistically significant difference in visual 
acuity outcomes as compared to cases without ILM peeling (1, 2, 3).  
Table 7: BCVA result comparison  
 Mean Preoperative 
BCVA 
Mean Postoperative 
BCVA 
Mean change 
in BCVA 
Current study: 
PPV/ILM peel 
	0.59	±	0.29 	0.37	±	0.25 	0.22 
Jackson et al. (2013): 
PPV/ILM peel 
 
0.64 ± 0.32 
 
0.41 ± 0.26 
 
0.23 
Current study: 
PPV only 
	0.77	±	0.37 	0.53	±	0.37 	0.24 
Jackson et al. (2013): 
PPV only 
 
0.72 ± 0.46 
 
0.44 ± 0.37 
 
0.28 
 
Neither group in our study had a statistically significant increase in BCVA within 
the short-term follow-up of 3 months. There was also no statistically significant 
difference between the change in BCVA for the two groups at this time point.  Short-term 
visual acuity improvement was found with both surgical methods in this study, although 
it was not statistically significant with either technique. This result mostly agrees with 
results found in other studies for short-term visual acuity after PPV surgery with or 
without ILM peeling. Al-Abdulla et al. (2004) reported better visual acuity results at the 3 
month postoperative follow-up for primary macular holes treated without ILM peel as 
compared to those treated with ILM peel (2). However,macular holes and VMT have 
inherent anatomical differences, and thus pre-operative BCVA and visual acuity 
improvement may not be comparable.  
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 Our data for CMT indicates a statistically significant decrease in mean CMT for 
Group 1 (416.4 ± 130.7 µm preoperatively to 296.8 ± 72.0 postoperatively) and Group 2 
(511.4 ± 254.0 µm preoperatively to 306.1 ± 71.6 µm postoperatively). There was no 
statistically significant difference in the CMT decrease when comparing the two surgical 
techniques, and this result is consistent with current scientific literature (18). Schecet et al. 
(2016) investigated CMT outcomes following PPV with and without ILM peeling for 
ERM. They found no significant difference in outcomes between the two techniques but 
reported a decreased change in average CMT for the group with ILM peeling, which is 
consistent with findings in our current study (18). 
 A study by Sonmez et al. (2008) provided evidence of a correlation between 
visual acuity outcomes with preoperative vitreomacular structure, duration of symptoms, 
and preoperative CMT (21). Their study indicated that eyes with greater CMT before 
surgery, as found by OCT, had greater visual acuity improvement after surgery (21). Our 
current study found similar results. Cases without ILM peeling had a greater mean CMT 
preoperatively, worse BCVA preoperatively, and a greater mean improvement in visual 
acuity postoperatively. This greater change in VA with ILM peeling may be due to the 
greater pre-operative CMT, as suggested by Sonmez et al. (2008). The CMT is related to 
the amount of macular abnormality found in VMT syndrome. Eyes with an increase in 
the CMT experience more tractional force applied to the macula and thus often have 
greater macular abnormalities (21). Therefore, relief of traction causing increased CMT 
and macular abnormalities may have the potential for better final visual acuity outcomes 
as compared to eyes with minimal increase in CMT and macular abnormalities due to 
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traction. However, other factors such as duration of VMT may affect final visual acuity 
outcomes and should be considered in future studies.   
 As with many retrospective clinical case studies, this study has limitations due to 
patient compliance in follow up. Follow up dates used in this study were based on 
available data, which ranged from one month to five months for short-term follow-up and 
9 months to 10 years for long-term follow-up. This range likely contributed to the 
inconclusiveness of the short-term visual acuity data and may have had an impact on 
long-term visual acuity data as well.  This case series also did not take into account 
secondary diagnoses that may have resulted in poor, long-term visual outcomes, such as 
glaucoma, proliferative diabetic retinopathy, and hypertension. Larger studies should 
consider categorization of patients based on overall health factors and secondary 
diagnoses to limit these potential confounding factors. However, the results of this study 
regarding recurrent formation of epiretinal membranes in cases without internal limiting 
membrane peeling may be useful in context with other clinical studies and could help 
vitreoretinal specialists make decisions about surgical techniques. The significant 
increase in visual acuity for both groups regardless of ILM peeling may be useful for 
clinicians and future research as well.  
 Continued development of pneumatic vitreolysis may be significant in decreasing 
the number of patients requiring surgery for VMT, but PPV with internal limiting 
membrane peeling should be considered when pneumatic vitreolysis fails to relieve 
traction. Our retrospective case series provides further evidence that there is may be no 
significant difference in long-term visual acuity between VMT cases receiving PPV with 
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ILM peeling or those receiving PPV alone, but further and more extensive studies should 
be conducted to supplement these findings. If further research confirms the findings 
reported here, surgeons should consider using ILM peeling as a measure for preventing 
postoperative epiretinal membrane formation requiring follow-up surgery. 
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